Clinical Trial Update: Breeze3:Study of Gabapentin Extended Release in the Treatment of Vasomotor Symptoms(Hot Flashes)in Postmenopausal Women [Phase 3]

View source ↗

Summary

Phase 3 study of extended-release gabapentin for vasomotor symptoms (hot flashes) in postmenopausal women completed; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hot Flashes
• Postmenopausal Vasomotor Symptoms

Drugs mentioned

• gabapentin extended release (gabapentin extended release)

Snippet

Sponsor: Depomed | Conditions: Hot Flashes | Phase 3 | Status: COMPLETED | Results posted: 2014-03-26